SUBSCRIBE
SUBSCRIBE

People

Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Business
Activist Fund Wants to Oust Ariad Pharmaceuticals CEO Harvey Berger
February 13, 2015
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Hospira CEO May Walk Away With More Than $80 Million After Pfizer Deal is Finalized
February 12, 2015
 · 
4 min read
Business
Pfizer Taps New UK Head of Innovative Pharmaceuticals
February 10, 2015
 · 
2 min read
$7.3 Million Parting Gift for Now-Former Teva Pharmaceutical Executive
Business
$7.3 Million Parting Gift for Now-Former Teva Pharmaceutical Industries Exec
February 10, 2015
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Business
FDA Commissioner to Step Down After Six Years
February 5, 2015
 · 
2 min read
Business
Sanofi to Name New CEO in Coming Weeks, As Uphill Battle to Fill Top Spot Finally Ends
February 5, 2015
 · 
3 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Business
Activist Investor Ackman’s Pershing Square Secures a Seat On Zoetis Board
February 5, 2015
 · 
5 min read
Day in the Life of a CEO—Jim Bianco, CTI BioPharma
Biotech Bay
Day in the Life of a CEO—Jim Bianco, CTI BioPharma
February 3, 2015
 · 
6 min read
Business
Large Acucela Inc. Shareholder Wants to Oust Four Out of Five Board Members
February 3, 2015
 · 
1 min read
Business
Three Rejections on the Board, Fruitless CEO Hunt Overshadows Sanofi
January 30, 2015
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
Amber Therapeutics strengthens its Board and Leadership team, opens UK headquarters and expands EU feasibility study for mixed urinary incontinence, increasing momentum towards a pivotal trial in the US
February 24, 2026
 · 
5 min read
Press Releases
ASTRA Therapeutics appoints Industry Leader Fabian Kausche as Chairman of the Board of Directors
February 24, 2026
 · 
4 min read
Press Releases
ImmunityBio Founder Dr. Patrick Soon-Shiong to Speak at Milken Institute and Richard Nixon Foundation “Cancer 2035: A Roadmap for the Future” Summit
February 24, 2026
 · 
5 min read
Press Releases
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
February 24, 2026
 · 
5 min read
Press Releases
Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board
February 24, 2026
 · 
5 min read
Press Releases
Biomerics Appoints Tyler Reed as the New President of the Micro Metals Division
February 23, 2026
 · 
2 min read
Press Releases
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
February 23, 2026
 · 
4 min read
Press Releases
Neutrolis Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors as Executive Director
February 23, 2026
 · 
3 min read
Press Releases
Synthekine Appoints Biotechnology and Pharmaceutical Industry Veteran John A. Orwin as Chair of its Board of Directors
February 23, 2026
 · 
2 min read
Press Releases
Mopec Group Announces Scott Nudelman as Senior Director, Service, Warranty and Quality
February 23, 2026
 · 
2 min read
Press Releases
BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman
February 23, 2026
 · 
6 min read
Press Releases
Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board
February 23, 2026
 · 
8 min read
Press Releases
Boston Scientific elects Cathy Smith and Christophe Weber to Board of Directors
February 23, 2026
 · 
2 min read
Press Releases
Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors
February 23, 2026
 · 
4 min read
Press Releases
Pelage Pharmaceuticals Appoints New Board Member and Expands Executive Leadership Team
February 23, 2026
 · 
4 min read
Press Releases
Merck Evolves Human Health Operating Structure to Support Portfolio Execution
February 23, 2026
 · 
5 min read
Press Releases
Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors
February 23, 2026
 · 
4 min read
Press Releases
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer
February 23, 2026
 · 
3 min read
Press Releases
IDEAYA Biosciences Announces Appointment of Dr. Theodora (Theo) Ross, M.D., Ph.D., as Chief Development Officer
February 23, 2026
 · 
5 min read
Press Releases
BioInvent Announces Nomination of Two New Board Members Ahead of 2026 Annual General Meeting
February 23, 2026
 · 
4 min read
Load More